Immunohistochemical analysis of differentiation in static and mixed prostate cancer spheroids

Journal of Cellular and Molecular Medicine

Volumn 7, Issue 2, 2003, Pages 180-186

  Song, Hong ^a,b   O'Connor, Kim C ^a,b   David, Odile ^b   Giordano, Carrie L ^a   Pappas LeBeau, Helena ^b   Clejan, Sanda ^b  

^a Tulane University   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokeratins; Differentiation; Mixing; Prostate cancer; PSA; Spheroid

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 8; PROSTATE SPECIFIC ANTIGEN; RAS PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MULTICELLULAR SPHEROID; PHENOTYPE; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR SPHEROID;

EID: 0141575437     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2003.tb00217.x     Document Type: Article

References (33)

1. Sutherland R.M., Cell and environmental interactions in tumor microregions: the multicell spheroid model, Science, 240: 177-184, 1988
2. dit Faute M.A., Laurent L., Ploton D., Poupon M.F., Jardillier J.-C., Bobichon H., Distinctive alterations of invasiveness, drug resistance and cell-cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant, Clin. Exp. Metastasis, 19: 161-168, 2002
3. Wartenberg M., Donmez F., Ling F.C., Acker H., Hescheler J., Sauer H., Tumor-induced angiogenesis studied in confrontation cultures of multicellular tumor spheroids and embryoid bodies grown from pluripotent embryonic stem cells, FASEB J., 15: 995-1005, 2001
4. Wenning L.A., Murphy R.M., Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids, Biotechnol Bioeng., 62: 562-575, 1999
5. St. Croix B., Rak J.W., Kapitain S., Sheehan C., Graham C.H., Kerbel R.S., Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells, J. Natl. Cancer Inst., 88: 1285-1296, 1996
6. Freed L.E., Marquis J.C., Vunjak-Novakovic G., Emmanual J., Langer R., Composition of cell-polymer cartilage implants, Biotechnol. Bioeng., 43:605-614, 1994
7. Sikavitsas V.I., Bancroft G.N., Mikos A.G., Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor, J. Biomed. Mater. Res., 62: 136-148, 2002
8. Tenen D.G., Disruption of differentiation in human cancer: AML shows the way, Nat. Rev. Cancer, 3: 89-101, 2003
9. Grönberg H., Prostate cancer epidemiology, Lancet, 361: 859-864, 2003
10. O'Connor K.C., Three-dimensional cultures of prostatic cells: tissue models for the development of novel anti-cancer therapies, Pharm. Res., 16: 486-493, 1999
11. Bonkhoff H., Remberger K., Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model, Prostate, 28: 98-106, 1996
12. Horoszewicz J.S., Leong S.S., Kawinski E., Karr J.P., Rosenthal H., Chu T.M., Mirand E.A., Murphy G.P., LNCaP model of human prostatic carcinoma, Cancer Res,. 43: 1809-1818, 1983
13. Hoosein N.M., Boyd D.D., Hollas W.J., Mazar A., Henkin J., Chung L.W., Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines, Cancer Commun., 3: 255-264, 1991
14. Lelkes P.I., Ramos E., Nikolaychik V.V., Wankowski D.M., Unsworth B.R., Goodwin T.J., GTSF-2: a new, versatile cell culture medium for diverse normal and transformed mammalian cells, In Vitro Cell Dev. Biol. Anim., 33: 344-351, 1997
15. Enmon R.M., O'Connor K.C., Song H., Lacks D.J., Schwartz D.K., Aggregation kinetics of well and poorly differentiated human prostate cancer cells, Biotechnol. Bioeng., 80: 580-588, 2002
16. Unsworth B.R., Lelkes P.I., Growing tissues in microgravity. Nat. Med., 4: 901-907, 1998
17. Margolis L., Hatfill S., Chuaqui R., Vocke C., Emmert-Buck M., Linehan W.M., Duray P.H., Long term organ culture of human prostate tissue in a NASA-designed rotating wall bioreactor, J. Urol., 161: 290-297, 1999
18. Zhau H.E., Goodwin T.J., Chang S.M., Baker T.L., Chung L.W.K., Establishment of a three-dimensional human prostate organoid coculture under microgravity-simulated conditions: evaluation of androgen-induced growth and PSA expression, In Vitro Cell. Dev. Biol. Anim., 33: 375-380, 1997
19. Chung L.W.K., Zhau H.E., Wu T.T., Development of human prostate cancer models for chemoprevention and experimental therapeutics studies, J. Cell. Biochem. Suppl., 28-29: 174-181, 1997
20. Rhee H.W., Zhau H.E., Pathak S., Multani A.S., Pennanen S., Visakorpi T., Chung L.W.K., Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel, In Vitro Cell. Dev. Biol. Anim., 37: 127-140, 2001
21. Stege R., Grande M., Carlström K., Tribukait B., Pousette Å., Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas, Clin. Cancer Res., 6: 160-165, 2000
22. Gurova K.V., Roklin O.W., Krivokrysenko V.I., Chumakov P.M., Cohen M.B., Feinstein E., Gudkov A.V., Expression of prostate specific antigen (PSA) is negatively regulated by p53, Oncogene, 21: 153-157, 2002
23. Wang L.G., Liu X.M., Kreis W., Budman D.R., Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binding consensus in the promoter of the PSA gene in LNCaP cells, Cancer Res., 57:714-719, 1997
24. Pervez S., Kirkland S.C., Epenetos A.A., Mooi W.J., Evans D.J., Krausz T., Effect of polarity and differentiation on antibody localization in multicellular tumour spheroid and xenograft models and its potential importance for in vivo immunotargeting, Int. J. Cancer, 44: 940-947, 1989
25. Ballangrud A.M., Yang W.-H., Dnistrian A., Lampen N.M., Sgouros G., Growth and characterization of LNCaP prostate cancer cell spheroids, Clin. Cancer. Res., 5(suppl): 3171s-3176s, 1999
26. Khaoustov V.I., Darlington G.J., Soriano H.E., Krishnan B., Risin D., Pellis N.R., Yoffe B., Induction of three-dimensional assembly of human liver cells by simulated microgravity, In Vitro Cell. Dev. Biol. Anim., 35: 501-509, 1999
27. Bostwick D.G., Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia, Cancer, 78: 330-336, 1996
28. Sherwood E.R., Theyer G., Steiner G., Berg L.A., Kozlowski J.M., Lee C., Differential expression of specific cytokeratin polypeptides in the basal and luminal epithelia of the human prostate, Prostate, 18: 303-314, 1991
29. Alberti I., Barboro P., Barbesino M., Sanna P., Pisciotta L., Parodi S., Nicolo G., Boccardo F., Galli S., Patrone E., Balbi C., Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer, J. Cell. Biochem., 79: 471-485, 2000
30. Oshima R.G., Baribault H., Caulin C., Oncogenic regulation and function of keratins 8 and 18, Cancer Metastasis Rev., 15: 445-471, 1996
31. Pankov R., Umezawa A., Maki R., Der C.J., Hauser C.A., Oshima R.G., Oncogene activation of human keratin 18 in transcription via the Ras signal transduction pathway, Proc. Natl. Acad. Sci. U.S.A., 91: 873-877, 1994
32. O'Connor, K.C., Enmon, R.M., Dotson, R.S., Primavera, A.C., Clejan, S., Characterization of autocrine growth factors, their receptors and extracellular matrix present in three-dimensional cultures of DU 145 human prostate carcinoma cells grown in simulated microgravity, Tissue Eng., 3: 161-171, 1997
33. Guo Y., Pili R., Passaniti A., Regulation of prostate-specific antigen gene expression in LNCaP human prostatic carcinoma cells by growth, dihydrotestosterone, and extracellular matrix, Prostate, 24: 1-10, 1994